Advertisement

Introduction and Technical Aspects

Part of the Essentials in Cytopathology book series (EICP, volume 4)

Abstract

Needle aspiration cytology has been in use for many decades and dates back at least to the early part of the nineteenth century. Sir James Paget is credited for aspirating malignant cells from a breast cancer patient in 1853. Much of the early experience of aspiration biopsy was not with “fine” needles but with larger bore cutting needles. The popularity of this simple procedure has largely been because of its cost effectiveness as well as the inherent qualities of the procedure itself: low complication rate, rapidity, and high diagnostic accuracy.

Keywords

Technical Aspect Breast Lesion Myoepithelial Cell Gray Zone Direct Smear 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected Reading

  1. al-Kaisi N: The spectrum of the “gray zone” in breast cytology. A review of 186 cases of atypical and suspicious cytology. Acta Cytol 1994, 38:898–908.PubMedGoogle Scholar
  2. Boerner S, Sneige N: Specimen adequacy and false-negative diagnosis rate in fine-needle aspirates of palpable breast masses. Cancer 1998, 84:344–348.PubMedCrossRefGoogle Scholar
  3. Kanhoush R, Jorda M, Gomez-Fernandez C, Wang H, Mirzabeigi M, Ghorab Z, Ganjei-Azar P: “Atypical” and “suspicious” diagnoses in breast aspiration cytology. Cancer 2004, 102:164–167.PubMedCrossRefGoogle Scholar
  4. Lee WY, Wang HH: Fine-needle aspiration is limited in the classification of benign breast diseases. Diagn Cytopathol 1998, 18:56–61.PubMedCrossRefGoogle Scholar
  5. Sidawy MK, Stoler MH, Frable WJ, Frost AR, Masood S, Miller TR, Silverberg SG, Sneige N, Wang HH: Interobserver variability in the classification of proliferative breast lesions by fine-needle aspiration: results of the Papanicolaou Society of Cytopathology Study. Diagn Cytopathol 1998, 18:150–165.PubMedCrossRefGoogle Scholar
  6. Sneige N: Fine-needle aspiration of the breast: a review of 1,995 cases with emphasis on diagnostic pitfalls. Diagn Cytopathol 1993, 9:106–112.PubMedCrossRefGoogle Scholar
  7. Tabbara SO, Frost AR, Stoler MH, Sneige N, Sidawy MK: Changing trends in breast fine-needle aspiration: results of the Papanicolaou Society of Cytopathology Survey. Diagn Cytopathol 2000, 22:126–130.PubMedCrossRefGoogle Scholar
  8. Veneti S, Daskalopoulou D, Zervoudis S, Papasotiriou E, Ioannidou-Mouzaka L: Liquid-based cytology in breast fine needle aspiration. Comparison with the conventional smear. Acta Cytol 2003, 47:188–192.PubMedGoogle Scholar
  9. Xie HB, Salhadar A, Haara A, Gabram S, Selvaggi SM, Wojcik EM: How stereotactic core-needle biopsy affected breast fine-needle aspiration utilization: an 11-year institutional review. Diagn Cytopathol 2004, 31:106–110.PubMedCrossRefGoogle Scholar
  10. Young NA, Mody DR, Davey DD: Diagnosis and subclassification of breast carcinoma by fine-needle aspiration biopsy: results of the interlaboratory comparison program in non-gynecologic cytopathology. Arch Pathol Lab Med 2002,126:1453–1457.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Personalised recommendations